GSK3B and Alzheimer disease: In SH‐SY5Y and mouse primary cells, we have demonstrated that an increased phosphorylation of tau by kinase GSK3β, as occurs in Alzheimer disease, can modulate the levels and enzymatic activity of cholinergic AChE.